U.S., May 24 -- ClinicalTrials.gov registry received information related to the study (NCT06987214) titled 'REGEND001 Autologous Basal Layer Stem Cell Transplantation for Bronchiectasis: A Translational Application Study' on May 14.
Brief Summary: This clinical trial aims to evaluate the safety and efficacy of REGEND001, an autologous basal layer stem cell transplantation therapy, in patients with chronic structural lung disease (bronchiectasis). The treatment involves harvesting bronchial basal layer stem cells from the patient, expanding them ex vivo, and reintroducing them via bronchoscopic infusion to repair damaged lung tissue.
Study Start Date: June 30
Study Type: INTERVENTIONAL
Condition:
Bronchiectasis Adult
Intervention:
BIO...